Monarch Partners Asset Management LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,360,000
+56.3%
25,751
+81.3%
0.31%
+44.3%
Q2 2020$870,000
+8.3%
14,2010.0%0.21%
-24.8%
Q1 2020$803,000
+23.9%
14,201
+24.7%
0.28%
+95.8%
Q4 2019$648,000
+41.8%
11,386
+33.4%
0.14%
+108.7%
Q3 2019$457,000
+1.8%
8,536
+13.4%
0.07%
+7.8%
Q2 2019$449,000
+14.5%
7,526
+19.5%
0.06%
+8.5%
Q1 2019$392,000
-30.1%
6,296
-32.0%
0.06%
-27.2%
Q4 2018$561,0009,2560.08%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders